Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(60.0%)
N/A
2(40.0%)
5Total
Phase 4(3)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07222176Not ApplicableActive Not Recruiting

Effects of P-TIOX and Tixel Combined on Reducing Eye Wrinkles

Role: lead

NCT06074302Not ApplicableCompleted

Hyaluronic Filler for Improvement of Radial Cheek Lines

Role: lead

NCT06225492Phase 4Completed

DaxibotulinimtoxinA for Treatment of Platysmal Neck Bands

Role: lead

NCT05471947Phase 4Completed

TCA 15% Chemical Peel for Improvement in Hand Lentigines

Role: lead

NCT05039723Phase 4Completed

Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational

Role: lead

All 5 trials loaded